[1] Buckmiller L M, Richter G T, Suen J Y. Diagnosis and management of hemangiomas and vascular malformations of the head and neck[J]. ORAL DIS, 2010,16(5):405-418.
[2] Hassanein A H, Mulliken J B, Fishman S J, et al. Venous malformation: risk of progression during childhood and adolescence[J]. Ann Plast Surg, 2012,68(2):198-201.
[3] Mulliken J B, Glowacki J. Classification of pediatric vascular lesions[J]. Plastic & Reconstructive Surgery, 1982,70(1):120-121.
[4] Horbach S E, Rigter I M, Smitt J H, et al. Intralesional Bleomycin Injections for Vascular Malformations: A Systematic Review and Meta-Analysis[J]. PLAST RECONSTR SURG, 2016,137(1):244-256.
[5] GeraldM. Legiehn M F M K. Venous Malformations: Classification,Development, Diagnosis, and Interventional Radiologic Management[J]. Radiol Clin N Am, 2008,46(3):545-597.
[6] Akita H, Yamada Y, Ito Y, et al. Retroperitoneal low-flow vascular malformations: characteristic MRI findings correlated with histopathological findings[J]. ABDOM IMAGING, 2015,40(6):1713-1720.
[7] Kolokythas A. Vascular Malformations and Their Treatment in the Growing Patient[J]. Oral Maxillofacial Surg Clin of North Am, 2015,28(1):91-104.
[8] 罗晓莉, 江 丽, 朱建平. 彩色多普勒超声诊断先天性下腔静脉畸形的临床应用价值[J]. 中华医学超声杂志(电子版), 2014,11:125-130.
[9] 郑家伟. 口腔颌面_头颈部静脉畸形诊治指南[J]. 中国口腔颌面外科杂志, 2011, 9(6):510-517.
[10] Thawait S K, Puttgen K, Carrino J A, et al. MR imaging characteristics of soft tissue vascular anomalies in children.[J]. Eur J Pediatr, 2013,172(5):591-600.
[11] 侯 昉. 儿童静脉畸形的诊断与治疗概述_侯昉[J]. 实用医院临床杂志, 2017,14.(1):138-140.
[12] Zhu J, Ren J, Zhang W, et al. Characterization of microparticles in patients with venous malformations of the head and neck[J]. ORAL DIS, 2017,23,(1):110-119.
[13] Zhong LP O A Y W. Surgical management of_x000a_solitary venous malformation in the midcheek region[J]. Oral and Maxillofacial Surgery,2011,114(2):160-166.
[14] Yajing Qiu M H C M, Xiaojie Hu M P Y J, Gang Ma M P. Outcomes and Complications of_x000a_Sclerotherapy for Venous Malformations[J]. VASC ENDOVASC SURG, 2013,47(6)454-461.
[15] G. Liu X L W L, X. Lu X H M L. Ultrasound-guided Intralesional Diode Laser Treatment of Congenital_x000a_Extratruncular Venous Malformations: Mid-term Results[J]. Eur J Vasc Endovasc Surg, 2014,47(5):558-564.
[16] 邱胜达, 陈 辉, 林晓曦. 静脉畸形的治疗进展[J]. 组织工程与重建外科杂志, 2014,10(4):225-227.
[17] Yun W, Kim Y, Lee K, et al. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: Analysis of patient self-assessment and imaging[J]. J VASC SURG, 2009,50(3):581-589.
[18] Puig S, Casati B, Staudenherz A, et al. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy[J]. ORAL DIS, 2005,53(1):35-45.
[19] Haruko Miyamoto A B I S, Nobuoki Kohno B A S K. Differential secretion of cytokines and adhesion molecules by HUVEC stimulated with low concentrations of bleomycin-main[J]. CELL IMMUNOL, 2002,219(2):73-81.
[20] Yamamoto T. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?[J]. ARCH DERMATOL RES, 2006,297(8):333-344.
[21] Wang C, Gao Q, Fu F, et al.[Treatment of hemangioma in oral and maxillofacial region with pingyangmycin injection][J]. Hua Xi Kou Qiang Yi Xue Za Zhi, 2000,18(5):317-319.
[22] Zheng Q T.[Local injection of bleomycin A 5 in children with hemangiomas. Analysis of 210 cases][J]. Zhonghua Wai Ke Za Zhi, 1991,29(5):290-291, 334.
[23] Renbing Jia M P, Shiqiong Xu M, Xiaolin Huang M, et al. Pingyangmycin as First-Line Treatment for Low-FlowOrbital_x000a_or Periorbital Venous Malformations_x000a_Evaluation of 33 Consecutive Patients[J]. JAMA OPHTHALMOL, 2014,132(8):942-948.
[24] Yue H, Qian J, Elner V M, et al. Treatment of orbital vascular malformations with intralesional injection of pingyangmycin[J]. Br J Ophthalmol, 2013,97(6):739-745.
[25] Zhang J, Haibo L I, Zhou S, et al. Comparison between absolute ethanol and bleomycin for the treatment of venous malformation in children[J]. EXP THER MED, 2013,6(2):305-309.
[26] Bajpai H, Bajpai S. Comparative analysis of intralesional sclerotherapy with sodium tetradecyl sulfate versus bleomycin in the management of low flow craniofacial soft tissue vascular lesions[J]. J Maxillofac Oral Surg, 2012,11(1):13-20.
[27] David C. G. Sainsbury, B. Med. Sci. Hons. M B B S, Gareth Kessell M B C B, et al. Intralesional Bleomycin Injection Treatment for_x000a_Vascular Birthmarks: A 5-Year Experience at a_x000a_Single United Kingdom Unit[J]. PLAST RECONSTR SURG, 2011,11(1):13-20.
[28] Jessica Spence B O T K. PERCUTANEOUS TREATMENT OF FACIAL VENOUS_x000a_MALFORMATIONS: A MATCHED COMPARISON OF ALCOHOL_x000a_AND BLEOMYCIN SCLEROTHERAPY[J]. Wiley Periodicals, 2010,33(1):125-130.
[29] Li J, Chen J, Zheng G, et al. Digital Subtraction Angiography-Guided Percutaneous Sclerotherapy of Venous Malformations With Pingyangmycin and/or Absolute Ethanol in the Maxillofacial Region[J]. J ORAL MAXIL SURG, 2010,68(9):2258-2266.
[30] Rui Hou D A J G, Liang Kong D A G L. A clinical study of ultrasound-guided intralesional_x000a_injection of bleomycin A5 on venous malformation in cervicalfacial_x000a_region in China[J]. J VASC SURG, 2010,51(4):940-945.
[31] Spence J, Krings T, TerBrugge K G, et al. Percutaneous Sclerotherapy for Facial Venous_x000a_Malformations: Subjective Clinical and Objective_x000a_MR Imaging Follow-up Results[J]. AJNR Am J Neuroradiol, 2010,31(5):955-960.
[32] Zhi K, Wen Y, Li L, et al. The role of intralesional Pingyangmycin in the treatment of venous malformation of facial and maxillary region[J]. INT J PEDIATR OTORHI, 2008,72(5):593-597.
[33] Muir T, Kirsten M, Fourie P, et al. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations[J]. PEDIATR SURG INT, 2004,19(12):766-773.
[34] Lee HY L K R Y. Bleomycin-induced flagellate erythema:_x000a_a case report and review of the literature.[J]. ONCOL LETT, 2014,8(2):933-935.
[35] Faheem UlHaq M S M M, And CliffordR. Weiss M. Bleomycin foam treatment of_x000a_venous malformations: a promising agent for effective treatment with_x000a_minimal swelling.[J]. J VASC INTERV RADIOL, 2015,26(10):1484-1493.
[36] Eivazi B, Werner J A. Extracranial vascular malformations (hemangiomas and vascular malformations) in children and adolescents-diagnosis, clinic, and therapy[J]. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2014,13:(1):2.
[37] Diolaiuti S, Iizuka T, Schroth G, et al. Orbital venous malformation: percutaneous treatment using an electrolytically detachable fibred coil[J]. ACTA OPHTHALMOL, 2009,87(2):229-232.
[38] Gustav Andreisek M D N P. MR_x000a_imaging-guided percutaneous sclerotherapy of peripheral_x000a_venous malformations with a clinical 1.5-T_x000a_unit: a pilot study.[J]. J VASC INTERV RADIOL, 2009,20(7):879-887.
[39] Wong G A, Armstrong D C, Robertson J M. Cardiovascular collapse during ethanol sclerotherapy in a pediatric patient.[J]. PEDIATR ANESTH, 2006,16(3)343-346.
[40] Triana P, Dore M, Cerezo V N, et al. Sirolimus in the Treatment of Vascular Anomalies[J]. EUR J PEDIATR SURG, 2016,27(1):86-90.
[41] Salloum R, Fox C E, Allende C A, et al. Response of Blue Rubber Bleb Nevus Syndrome to Sirolimus Treatment[J]. PEDIATR BLOOD CANCER, 2016,63(11):1911-1914.
[42] Blaise S C M R H. Treatment of Low-flow Vascular Malformations by Ultrasound-guided Sclerotherapy with Polidocanol Foam: 24 Cases and Literature Review[J]. Eur J Vasc Endovasc Surg, 2011:412-417.